Literature DB >> 21420234

Endogenous activated protein C is essential for immune-mediated cancer cell elimination from the circulation.

G L van Sluis1, L W Brüggemann, C T Esmon, P W Kamphuisen, D J Richel, H R Büller, C J F van Noorden, C A Spek.   

Abstract

Fibrinogen and platelets play an important role in cancer cell survival in the circulation by protecting cancer cells from the immune system. Moreover, endogenous activated protein C (APC) limits cancer cell extravasation due to sphingosine-1-phosphate receptor-1 (S(1)P(1)) and VE-cadherin-dependent vascular barrier enhancement. We aimed to study the relative contribution of these two mechanisms in secondary tumor formation in vivo. We show that fibrinogen depletion limits pulmonary tumor foci formation in an experimental metastasis model in C57Bl/6 mice but not in NOD-SCID mice lacking a functional immune system. Moreover, we show that in the absence of endogenous APC, fibrinogen depletion does not prevent cancer cell dissemination and secondary tumor formation in immune-competent mice. Overall, we thus show that endogenous APC is essential for immune-mediated cancer cell elimination.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21420234      PMCID: PMC3159049          DOI: 10.1016/j.canlet.2011.02.038

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  39 in total

1.  Inhibition of endothelial cell-mediated generation of activated protein C by direct and antithrombin-dependent thrombin inhibitors.

Authors:  Rikard Linder; Siw Frebelius; Katarina Jansson; Jesper Swedenborg
Journal:  Blood Coagul Fibrinolysis       Date:  2003-02       Impact factor: 1.276

2.  Effect of different types of thrombin inhibitors on thrombin/thrombomodulin modulated activation of protein C in vitro.

Authors:  C Mattsson; A Menschik-Lundin; S Nylander; E Gyzander; J Deinum
Journal:  Thromb Res       Date:  2001-12-15       Impact factor: 3.944

3.  In vivo natural killer cell activities revealed by natural killer cell-deficient mice.

Authors:  S Kim; K Iizuka; H L Aguila; I L Weissman; W M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

Review 4.  Coagulation proteases and human cancer.

Authors:  M T Sampson; A K Kakkar
Journal:  Biochem Soc Trans       Date:  2002-04       Impact factor: 5.407

5.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited.

Authors:  Isaiah J Fidler
Journal:  Nat Rev Cancer       Date:  2003-06       Impact factor: 60.716

6.  Endogenous activated protein C limits cancer cell extravasation through sphingosine-1-phosphate receptor 1-mediated vascular endothelial barrier enhancement.

Authors:  Geerte L Van Sluis; Tatjana M H Niers; Charles T Esmon; Wikky Tigchelaar; Dick J Richel; Harry R Buller; Cornelis J F Van Noorden; C Arnold Spek
Journal:  Blood       Date:  2009-07-01       Impact factor: 22.113

7.  Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia.

Authors:  Rafal Pawlinski; Brian Pedersen; Gernot Schabbauer; Michael Tencati; Todd Holscher; William Boisvert; Patricia Andrade-Gordon; Rolf Dario Frank; Nigel Mackman
Journal:  Blood       Date:  2003-10-23       Impact factor: 22.113

8.  Activated protein C signals through the thrombin receptor PAR1 in endothelial cells.

Authors:  Matthias Riewald; Ramona J Petrovan; Aaron Donner; Wolfram Ruf
Journal:  J Endotoxin Res       Date:  2003

9.  Protein kinase C modifications of VE-cadherin, p120, and beta-catenin contribute to endothelial barrier dysregulation induced by thrombin.

Authors:  Maria Konstantoulaki; Panos Kouklis; Asrar B Malik
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-05-09       Impact factor: 5.464

10.  Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis.

Authors:  Eric Camerer; Aisha A Qazi; Daniel N Duong; Ivo Cornelissen; Rommel Advincula; Shaun R Coughlin
Journal:  Blood       Date:  2004-03-18       Impact factor: 22.113

View more
  7 in total

1.  Contributions of thrombin targets to tissue factor-dependent metastasis in hyperthrombotic mice.

Authors:  N Yokota; A Zarpellon; S Chakrabarty; V Y Bogdanov; A Gruber; F J Castellino; N Mackman; L G Ellies; H Weiler; Z M Ruggeri; W Ruf
Journal:  J Thromb Haemost       Date:  2014-01       Impact factor: 5.824

2.  Prospective evaluation of protein C and factor VIII in prediction of cancer-associated thrombosis.

Authors:  A J Tafur; G Dale; M Cherry; J D Wren; A S Mansfield; P Comp; S Rathbun; J A Stoner
Journal:  Thromb Res       Date:  2015-10-08       Impact factor: 3.944

Review 3.  Endothelial cell protein C receptor: a multiliganded and multifunctional receptor.

Authors:  L Vijaya Mohan Rao; Charles T Esmon; Usha R Pendurthi
Journal:  Blood       Date:  2014-07-21       Impact factor: 22.113

4.  Endothelial cell protein C receptor promotes MGC803 gastric cancer cells proliferation and migration by activating ERK1/2.

Authors:  Qingling Wang; Qingru Liu; Tianyuan Wang; Hongli Yang; Zhengjie Han; Peng Zhang
Journal:  Med Oncol       Date:  2015-04-21       Impact factor: 3.064

5.  Treatment with activated protein C (aPC) is protective during the development of myocardial fibrosis: an angiotensin II infusion model in mice.

Authors:  Mryanda J Sopel; Nicole L Rosin; Alec G Falkenham; Michael Bezuhly; Charles T Esmon; Timothy D G Lee; Robert S Liwski; Jean-Francois Légaré
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

6.  Soft fibrin gels promote selection and growth of tumorigenic cells.

Authors:  Jing Liu; Youhua Tan; Huafeng Zhang; Yi Zhang; Pingwei Xu; Junwei Chen; Yeh-Chuin Poh; Ke Tang; Ning Wang; Bo Huang
Journal:  Nat Mater       Date:  2012-07-01       Impact factor: 43.841

7.  Activated protein C upregulates ovarian cancer cell migration and promotes unclottability of the cancer cell microenvironment.

Authors:  Hamda Althawadi; Halema Alfarsi; Samaher Besbes; Shahsoltan Mirshahi; Elodie Ducros; Arash Rafii; Marc Pocard; Amu Therwath; Jeannette Soria; Massoud Mirshahi
Journal:  Oncol Rep       Date:  2015-06-15       Impact factor: 3.906

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.